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ORIGINAL ARTICLERadiomic Analysis Reveals Prognostic Information in T1-Weighted
Baseline Magnetic Resonance Imaging in Patients
With Glioblastoma
Michael Ingrisch, PhD,* Moritz Jörg Schneider, MSc,* Dominik Nörenberg, MD,†
Giovanna Negrao de Figueiredo, MD,† Klaus Maier-Hein, PhD,‡ Bogdana Suchorska, MD,§
Ulrich Schüller, MD,||¶ Nathalie Albert, MD,# Hartmut Brückmann, MD,** Maximilian Reiser, MD,†
Jörg-Christian Tonn, MD,§ and Birgit Ertl-Wagner, MD†Objectives: The aim of this study was to investigate whether radiomic analysis
with random survival forests (RSFs) can predict overall survival from T1-
weighted contrast-enhanced baseline magnetic resonance imaging (MRI) scans
in a cohort of glioblastoma multiforme (GBM) patients with uniform treatment.
Materials and Methods: This retrospective study was approved by the institu-
tional review board and informed consent was waived. The MRI scans from
66 patients with newly diagnosed GBM from a previous prospective study were
analyzed. Tumors were segmented manually on contrast-enhanced 3-dimensional
T1-weighted images. Using these segmentations, P = 208 quantitative image fea-
tures characterizing tumor shape, signal intensity, and texture were calculated in
an automated fashion. On this data set, an RSF was trained using 10-fold cross
validation to establish a link between image features and overall survival, and
the individual risk for each patient was predicted. The mean concordance index
was assessed as a measure of prediction accuracy. Association of individual risk
with overall survival was assessed using Kaplan-Meier analysis and a univariate
proportional hazards model.
Results:Mean overall survivalwas 14months (range, 0.8–85months).Mean con-
cordance index of the 10-fold cross-validated RSF was 0.67. Kaplan-Meier anal-
ysis clearly distinguished 2 patient groups with high and low predicted individual
risk (P = 5.5 10−5). Low predicted individual mortality was found to be a favor-
able prognostic factor for overall survival in a univariate Cox proportional hazards
model (hazards ratio, 1.038; 95% confidence interval, 1.015–1.062; P = 0.0059).
Conclusions: This study demonstrates that baseline MRI in GBM patients con-
tains prognostic information, which can be accessed by radiomic analysis
using RSFs.
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Copyright © 2017 Wolters Kluwer HG lioblastoma multiforme (GBM) is a malignant primary brain tu-mor with a poor prognosis and median survival times between
11 and 15 months.1–6 In clinical routine, GBMs are usually diagnosed
and followed-up with MRI. Extracting in-depth prognostic data and
novel imaging biomarkers from these routinely acquired image data sets
would have a high relevance for personalized and precise therapeutic
decision making and potentially for the development and implementa-
tion of new treatment approaches.7,8
Recently, radiomic approaches have emerged as promising tools
to enhance information attainable from imaging by means of automated
high-throughput analysis combined with machine learning.7,9,10 This
relies on converting radiological images into a large number of quanti-
tative image features that characterize numerous aspects of the image.
The resulting parameter space is then subjected to data mining methods
to extract meaningful information. Recently, this was used, for example,
to classify prostate cancer11 or breast cancer12 based onMRI scans or to
predict survival7,13 or distant metastases14 in non–small cell lung cancer
based on CT data.
A radiomic analysis generates a high-dimensional parameter
space, where the number of parameters typically exceeds the number
of samples by far. This inherent quality of radiomic data sets poses a
significant challenge for statistical data analysis: the large number of
image features renders classical regression approaches unfeasible and
potentially strong correlations between similar image features compli-
cate the selection and identification of strong predictive variables. Such
high-dimensional problems may be addressed with machine learning
methods such as random forests (RFs) originally proposed for classifi-
cation problems.15 Random forests have recently been extended to deal
with right-censored survival data16,17; the outcome variable of such ran-
dom survival forests (RSFs) is an individual measure of patient risk as a
predictor of overall survival.18 Unlike conventional survival models,
RSFs are nonparametric, do not rely on restrictive assumptions such
as proportional hazards, and can easily incorporate variable interac-
tions. Random survival forests can also be used to identify prognostic
variables and have been used to identify risk factors in patients with sys-
tolic heart failure19 and to identify variables associated with recurrence
of hepatocellular carcinoma.20
The purpose of this retrospective single center study was there-
fore to investigate whether a radiomic analysis with RSF can extract
prognostic information from T1-weighted contrast-enhanced (CE) base-
line MRI scans in a cohort of GBM patients with uniform treatment.MATERIALS AND METHODS
Patients and MRI
This retrospective study was approved by the institutional review
board of the Ludwig-Maximilian University, Munich, Germany
(241–15). Patients were included from a previous prospective study
(NCT0108986821), for which written informed consent had beenInvestigative Radiology • Volume 52, Number 6, June 2017
ealth, Inc. All rights reserved.
FIGURE 1. GBM segmentation of contrast-enhancing tumor volume on 3 T CE T1-weighted images of a 58-year-old GBMpatient with an overall survival
of 79 months. After initial imaging, the patient received microsurgery and completed RCX. Axial (A), coronal (B), and sagittal slice (C), along with the
segmentation that was used for feature calculation. Figure 1 can be viewed online in color at www.investigativeradiology.com.
Investigative Radiology • Volume 52, Number 6, June 2017 Radiomics in Patients With Glioblastomaobtained. This initial prospective trial investigated the prognostic value
of positron emission tomography on survival of GBM patients with
standardized therapy, whereas in the present manuscript, we analyze
the prognostic value of baseline MRI data. Retrospective informed con-
sent for the additional data analysis was waived by the institutional re-
view board. Inclusion range was February 2007 to January 2010, the
date of last follow-up was February 28, 2014, and the study end point
was overall survival. Inclusion criteria were as follows: histologically
proven GBM by stereotactic biopsy or by open tumor resection accord-
ing to the World Health Organization classification,1 no prior treatment
such as radiotherapy or chemotherapy, no history of surgery, baseline
MRI performed in our institution, and availability of 3-dimensional
(3D) CE T1-weighted baseline MRI scans.FIGURE 2. Correlationmatrix of the 208 image features, showing blocks with h
of features. Figure 2 can be viewed online in color at www.investigativeradiolo
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Copyright © 2017 Wolters Kluwer HMagnetic resonance imaging scans were acquired either on a
1.5 T system (Magnetom Symphony; Siemens Healthcare, Erlangen,
Germany) or on a 3 T system (Signa HDx; GE Healthcare, Milwaukee,
WI). Imaging parameters varied over time and magnet type (in-plane
resolution, 0.5–1 mm per pixel; slice thickness, 1.2–1.6 mm; echo time,
3.2–4.8 milliseconds; repetition time, 6–12 milliseconds; flip angle,
15 degrees).
Image Analysis and Feature Extraction
All MRI scans were reviewed independently in a randomized
fashion and blinded to the clinical data, only 3D CE T1-weighted MRI
scans were used for further analysis. Tumor segmentation was performed
using the Medical Image Interaction Toolkit.22 Contrast-enhancingigh positive (red) and negative (blue) correlations between several groups
gy.com.
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Ingrisch et al Investigative Radiology • Volume 52, Number 6, June 2017tumor regions were outlined manually on orthogonal slices of CE T1-
weighted images, after the contrast-enhancing tumor outline. Using this
contour information, the tumor surface was interpolated using the 3D
interpolation feature of Medical Image Interaction Toolkit. Contours
were added until the interpolated surface closely matched the tumor
outline on all slices. The resulting 3D tumor segmentation included
contrast-enhancing tumor tissue and central necrosis, these habitats
were not further discriminated. In patients with more than 1 lesion, each
lesion was contoured individually.
Before further analysis, images and segmentations were
resampled to 0.5 0.5 0.5 mm3 voxel size. Images were normalized
and contrast stretched to values from the minimum to the 98th percen-
tile. To turn images into mineable data, a set of P = 208 quantitative im-
age features was extracted in a fully automated fashion from each
segmentation on CE T1-weighted images. The shape of the segmenta-
tions was quantified by 9 features reflecting the total volume, surface
area, and sphericity among others.7 Twenty-four features describe
first-order intensity statistics such as median signal intensity or standard
deviation and were derived from histograms of the signal intensity.7 The
remaining features characterized tumor texture, conveying information
about the spatial arrangement of the signal intensity distribution. TheseFIGURE 3. Variable importance of prognostic features, as determined by min
362 www.investigativeradiology.com
Copyright © 2017 Wolters Kluwer Hinclude n = 13 Haralick features23,24 and n = 162 parameter-free thresh-
old adjacency statistics (pfTAS).24–26 The pfTAS features are derived
from images by thresholding the tumor volume and counting the num-
ber of adjacent black or white pixels for each pixel. In patients with
more than 1 lesion, the individual segmentations were combined and
image features were calculated cumulatively for all lesions.
Details about the individual features are described in the Supple-
mentary Appendix, Supplemental Digital Content 1, http://links.lww.
com/RLI/A307. Feature extraction routines were implemented in Py-
thon as nipype nodes,27 thus allowing for parallel computation in a fully
automated feature extraction pipeline. Calculations were performed on
a Linux workstation (Intel i7 CPU, 32 GB memory).
Statistical Analysis
Statistical modeling was performed in R (version 3.3.1,201628).
Univariate Cox proportional hazardsmodelswere used to assess the effects
of clinical variables (age, sex, mode of surgery, Karnofsky performance
score [KPS]) on overall survival; P values of the resulting univariate
models were adjusted for multiple testing using the Holm correction.29
An RSF17 was used to build a prognostic model for overall sur-
vival using the R package randomForestRSC.30 All P = 208 imageimal depth variable selection.
© 2017 Wolters Kluwer Health, Inc. All rights reserved.
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Investigative Radiology • Volume 52, Number 6, June 2017 Radiomics in Patients With Glioblastomafeatures were used for the analysis. Dimensionality reduction was per-
formed by “minimal depth variable selection”16,30 using the variable se-
lect routine30 with parameter settings ntree = 1000, node size = 2, and
nsplit = 10. The “minimal depth” of a variable is a statistic that can be
used to measure the “predictiveness” of this variable. A particular ad-
vantage of minimal depth is that it allows for robust identification of
predictive variables in high-dimensional data sets by thresholding.16
The covariates identified by this algorithm were then used to train final
prognostic RSFs (ntree = 1000, node size = 3, nsplit = 10), with the objec-
tive to predict an individual risk for each patient. To obtain unbiased es-
timates for each patient, training and prediction were performed using
10-fold cross validation, as implemented in the “mlr” framework.31
The median of the predicted individual risks was used to stratify
patients into 2 evenly sized groupswith low and high predicted risk; dif-
ferences in overall survival between these groups were assessed by
Kaplan-Meier analysis. A 2-sided log-rank test was used to test for a dif-
ference in overall survival between the 2 groups. Moreover, the associ-
ation of predicted risk with overall survival was assessed with a
univariate Cox proportional hazards models.




Of the 71 patients screened for study entry, 66 patients fulfilled
the inclusion criteria (mean age ± standard deviation, 66 ± 13 years;
age range, 26–79 years; 41 male; mean age ± standard deviation,
60 ± 13 years; age range, 30–78 years; 25 female; mean age ± standard
deviation, 58 ± 12.6 years; age range, 26–79 years). For n = 5 patients,
no 3DCEMRI scans could be retrieved. N = 32 patients underwent mi-
crosurgical resection; n = 34 patients underwent stereotactic biopsy. AllFIGURE 4. Association between predicted individual risk and overall survival.
of the predicted risk. The Kaplan-Meier plot shows clear separation of the gro
Figure 4 can be viewed online in color at www.investigativeradiology.com.
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Copyright © 2017 Wolters Kluwer Hpatients were scheduled to receive the same treatment regime consisting
of radiotherapy and concomitant and adjuvant temozolomide (RCx/
TMZ),21 n = 64 patients begun RCx, and n = 55 patients completed
RCx. Overall survival was measured from the date of initial MRI to the
date of death (if applicable). At the time of last follow-up, 58 patients
had died. Twelve patients had undergone imaging at 1.5 T, 54 patients
were imaged at 3 T.
Tumor Segmentation
While the majority of patients (n = 62) had a single contrast-
enhancing tumor, 4 patients presented with more than 1 contrast-
enhancing lesion,whichwere not directly connected. Representative tumor
segmentations on 3 T CE T1-weighted images are shown in Figure 1.
Image Features
Many of the 208 image features exhibit strong intrapatient corre-
lations, which can be appreciated in a heat map of the feature corre-
lation matrix, displayed in Figure 2. Large groups of features were
found to exhibit strong positive or negative correlations, most notably
pronounced for the several groups of pfTAS features, suggesting
feature redundancy.
Random Survival Forests
From the 208 features derived from the segmented tumors, the
minimal depth variable selection algorithm identified 20 features with
high importance, displayed in Figure 3. The featurewith the highest im-
portance was pfTAS_136, closely followed by pfTAS_103. The RSF
trained with these 20 features achieved mean concordance index of
67.7%. The predicted individual risks ranged from 10.1% to 53.8%,
with a median risk of 38.7%.Patients were stratified in 2 equal-sized groups by the median
ups with low (green) and high (blue) predicted risk.
www.investigativeradiology.com 363
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Age† 1.03 1.01–1.05 0.029
Sex female 1.36 0.80–2.3 0.50
KPS‡ 0.96 0.94–0.99 0.022
MGMT promoter methylated 0.38 0.22–0.67 0.0044
Mode of surgery (resection) 0.85 0.51–1.43 0.54
Predicted risk‡ 1.038 1.015–1.062 0.0059
*P values were adjusted for multiple testing using the Holm correction.
†Continuous scale, per 1 year increase.
‡Continuous scale, per 1% increase; KPS, 10% increments.
Boldface indicates a significant difference (P < 0.05).
KPS indicates Karnofsky performance score; MGMT, O6-methylguanine DNA
methyltransferase.
Ingrisch et al Investigative Radiology • Volume 52, Number 6, June 2017Association of Predicted Risk With Overall Survival
The association between predicted individual risk with overall
survival is illustrated by the Kaplan-Meier plot in Figure 4. Stratifying
all patients into 2 groups with low (coded in green) and high (coded
in blue) predicted risk, thresholded by the median value, reveals that
patients with longer overall survival accumulate in the group with low
predicted mortality. The survival curves of both groups are clearly sep-
arated. The difference, assessed with a 2-sided log-rank test, is highly
significant (P = 5.5  10−5). Figure 5 provides additional insight into
the relation between predicted risk and overall survival. Patients with
short overall survival tend to accumulate in the top left of the plot.
The median of predicted risk, indicated by the green line, separates this
cluster from most of the long-term survivors.
The associations between overall survival and clinical variables,
assessed with univariate Cox proportional hazard models, are displayed
in Table 1. Briefly, young age, higher initial KPS, methylated O6-
methylguanineDNAmethyltransferase promoter status, and low predicted
risk were identified as favorable prognostic covariates for overall survival
in univariate Cox proportional hazard models, whereas patient sex and
mode of surgery had no association with overall survival (Table 1).
DISCUSSION
In the present study, we analyzed CE T1-weighted MRI scans of
66 patients with newly diagnosed GBMwith a radiomic approach. From
each manually segmented contrast-enhancing lesion, 208 quantitativeFIGURE 5. Association between predicted risk and overall survival. The green
patient groups in Figure 4. The plot margins show the distribution of overall s
Figure 5 can be viewed online in color at www.investigativeradiology.com.
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Copyright © 2017 Wolters Kluwer Himage features were derived, resulting in a high-dimensional parameter
space. Avariable selection algorithm identified a small number of prog-
nostic features in this parameter space. These selected features were then
used to train final RSFs, which predicted individual risk for each in-
cluded subject. Stratifying the patients into 2 groups with high and
low predicted mortality revealed a strongly significant differenceline indicates the median predicted risk that was used to stratify
urvival (top) and predicted risk (right) in the patient sample.
© 2017 Wolters Kluwer Health, Inc. All rights reserved.
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Investigative Radiology • Volume 52, Number 6, June 2017 Radiomics in Patients With Glioblastomain overall survival and a proportional hazards model revealed a
highly significant association of the predicted risk with overall survival.
The set of important variables, as selected byminimal-depth var-
iable selection, contained mainly texture parameters from the pfTAS
and Haralick groups. In addition, 3 features characterizing tumor shape
and 1 feature from the first-order signal intensity groups were included
in the final set. The final model set did not contain any features charac-
terizing tumor size, but strong positive correlations between size-related
features and distinct texture features (eg, pfTAS136) indicate that infor-
mation about the contrast-enhancing tumor shape is implicitly included
in the final prognostic model.
In a recent study,13 a radiomic analysis was used to predict 2-year
survival from pretreatment computed tomography images in patientswith
lung cancer. In this study, the survival analysis was cast as a classification
task and random forests, among other machine learning classifiers, were
used to predict whether the patient survived longer than 2 years. A similar
classification approach was also used to predict progression-free survival
in nasopharyngeal carcinoma from T1-weighted MRI data.32 While this
is a valid strategy, the classification approach relies on the definition of an
arbitrary threshold value. Furthermore, the binary prediction whether pa-
tients survive longer than the set threshold is of limited value in a clinical
setting. In our study, we overcame these limitations by training RSFs on
the entire parameter space, with the purpose to develop a prognostic
model that does not rely on arbitrary thresholds and that predicts risk as
a continuous variable.
Random survival forests are a recent extension17 of the popular
random forest method and have been successfully used in the analysis
of genomic microarray data.18 This is a structurally similar problem
where sample sizes are limited and the large number of parameters
can exceed the number of samples, sometimes by far.18Moreover, many
of the genomic features may be highly correlated, whereas others may
have no association at all with the outcome variable. These properties
are also characteristic for many radiomics data sets. A feature selection
step before further analysis13 is often used to reduce the dimensionality
of the parameter space. In the present study, we have selected important
features by means of training an initial RSF on the entire data and
assessing the importance of variables by their minimal depth.16
Recently, Kickingereder et al33 have used a radiomic analysis to
predict survival of GBM patients from baseline MRI, including fluid-
attenuated inversion recovery as well as precontrast and postcontrast
T1 images. In their study, a feature selection step based on supervised
principal components was followed by proportional hazards regression.
Random survival forests, as used in our study, have the advantage to in-
trinsically identify important variables and, as a nonparametric method,
do not rely on a restrictive proportional hazards assumption. Important
features selected in Kickingereder et al33 were exclusively based on
fluid-attenuated inversion recovery images. Therefore, a further in-
crease in prognostic value of the presented approach can be expected
through inclusion of additional MRI scan contrasts or even imaging
modalities. Additional image contrast would also allow the use of auto-
mated tumor segmentation,34,35 thereby increasing scalability, repro-
ducibility, and hence clinical usefulness.
A limitation of the present study is the utilization of CE 3D T1-
weighted images only. Nevertheless, our analysis revealed a highly
prognostic value of this single MRI scan contrast alone. In this study,
tumors were contouredmanually, which is time-consuming and user de-
pendent. This highlights the need for automated tumor segmentation,
which would minimize user bias and enable larger-scale studies. In ad-
dition, we have focused the feature selection on the prognostic value of
the features. An important criterion for potential clinical application is
the stability of features with respect to volume definition, MR scanner,
or sequence settings,36 whichwe have not investigated. Due to the small
sample size of our study, we were not able to split our data into training
and test data sets. To circumvent this issue, predicted risk was calculated© 2017 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2017 Wolters Kluwer Husing 10-fold cross validation, thus ensuring an unbiased prediction
within this sample.37 Still, further studies and validation in independent
data sets are required to ensure that our approach generalizes to inde-
pendent data. Moreover, we have not tuned the hyperparameters of
our random forests, but have used the default settings of the R package
to demonstrate that a radiomics approach can extract prognostic infor-
mation from baseline MRI. Presumably, the prognostic performance
can be increased considerably, when hyperparameters are optimized
in further studies with larger sample sizes.
In conclusion, this study indicates that baseline CE T1-weighted
MRI in GBM patients contains prognostic information, which can be
accessed and used to build prognostic models by means of an ensemble
machine learning technique, RSFs. In the future, this approach can be
readily extended to include additional MR contrasts, functional imag-
ing, or even additional modalities such as CT or PET.REFERENCES
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